A Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Patients Undergoing Major Elective Spinal Surgery (SPINE Study)

NCT00211146 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

680

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia
Venous Thrombosis

Interventions

DRUG: epoetin alfa

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Collaborators

[object Object]